Jeevan Scientific Reports Zero Deviation in Preferential Issue Fund Utilization
Jeevan Scientific Technology Ltd · Others (Uncategorized) · 11 Nov 2026, 11:45 pm
Jeevan Scientific Reports Zero Deviation in Preferential Issue Fund Utilization Jeevan Scientific Technology Limited reported no deviation in utilizing proceeds from its preferential equity allotment for the quarter ended 30th Sep'26. Out of ₹3,074 lakhs raised on 2nd Jan'26, the company has deployed ₹414.46 lakhs toward capex (₹500 lakhs allocated), ₹279.97 lakhs for working capital (₹350 lakhs allocated), ₹300.53 lakhs for subsidiary requirements (₹500 lakhs allocated), ₹300.00 lakhs toward API/formulation unit acquisitions (₹1,000 lakhs allocated), and ₹189.04 lakhs for general corporate purposes (₹724 lakhs allocated).
Original exchange filing (PDF)
More announcements from Jeevan Scientific Technology Ltd
- Announcement under Regulation 30 (LODR)- 1. Resignation of Mr. Krishna Sainadh Kodati as Company Secretary and Compliance Officer of the Company. 2. Appointment of Mr. Ashok Babu Yaramaneni .... · 11 Nov 2026
- Outcome of the Board meeting held on 11.11.2026 · 11 Nov 2026
- Unaudited financial results for the quarter and half year ended 30.09.2026 · 11 Nov 2026
- Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve Intimation of .... · 11 Nov 2026
- Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015 · 01 Oct 2026
- Disclosure under Regulation 44(3) (Listing Obligations and Disclosure Requirements) Regulations, 2015. · 25 Sept 2026
- Outcome of 28th Annual General Meeting held on 25-09-2026 · 25 Sept 2026
- 28th Annual report · 04 Sept 2026
